CIAM
CLBT icon

Caitong International Asset Management’s Cellebrite CLBT Stock Holding History

Caitong International Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Buy
145
+65
+81% +$980 ﹤0.01% 1241
2025
Q4 		$1.44K Buy
80
+61
+321% +$1.09K ﹤0.01% 1342
2025
Q3 		$352 Sell
19
-234
-92% -$3.68K ﹤0.01% 1597
2025
Q2 		$4.05K Buy
+253
New +$4.51K ﹤0.01% 1104

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Caitong International Asset Management's CLBT Position: Q1 2026 in Review

Caitong International Asset Management increased its Cellebrite (CLBT) stake by 81% in Q1 2026, buying an estimated $980 and bringing the position to 145 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1241.

Caitong International Asset Management first reported a position in CLBT in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.05K in Q2 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Caitong International Asset Management held 145 shares of Cellebrite worth $2K as of Q1 2026.
  • Caitong International Asset Management bought 65 Cellebrite shares in Q1 2026, an estimated $980.
  • Cellebrite made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1241 holding.
  • Caitong International Asset Management first reported a position in Cellebrite in Q2 2025 and has held it in 4 quarters since.
  • Caitong International Asset Management's Cellebrite position peaked at $4.05K in Q2 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.